The pharmaceutical landscape for glucose is shifting, and transdermal GLP-1 delivery systems represent a potential advance. Unlike injections, this method offers a less invasive way to deliver GLP-1 therapies. These https://gerardwlnn827538.bloggazzo.com/39715809/glp-1-patches-a-novel-approach-to-blood-sugar-treatment